These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21516760)

  • 1. [Effects of long-term therapy with angiotensin-converting enzyme inhibitor and carvedilol on the heart remodeling process after non-Q-wave myocardial infarction].
    Bakaev RG; Strutynskiĭ AV; Kallaeva AN; Glazunov AB; Voronina MA; Pekhtereva DA; Moshkova NK; Chudnovskaia EA; Kochetkov BM
    Klin Med (Mosk); 2011; 89(1):23-6. PubMed ID: 21516760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dynamics of postinfarction left ventricular remodeling during long term use of perindopril, amiodarone, and beta-adrenoblockers].
    Kanorskiĭ SG; Staritskiĭ AG; Bozhko AA
    Kardiologiia; 2005; 45(3):31-5. PubMed ID: 15821705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol.
    Khattar RS; Senior R; Soman P; van der Does R; Lahiri A
    Am Heart J; 2001 Oct; 142(4):704-13. PubMed ID: 11579363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of cilazapril, carvedilol and their combination in preventing from left ventricular remodelling after acute myocardial infarction in rats.
    Yang Y; Tang Y; Ruan Y; Li Y; Zhou Y; Gao R; Chen J; Chen Z
    J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):31-5. PubMed ID: 11984745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN).
    Remme WJ; Riegger G; Hildebrandt P; Komajda M; Jaarsma W; Bobbio M; Soler-Soler J; Scherhag A; Lutiger B; Rydén L
    Cardiovasc Drugs Ther; 2004 Jan; 18(1):57-66. PubMed ID: 15115904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy.
    Doughty RN; Whalley GA; Walsh HA; Gamble GD; López-Sendón J; Sharpe N;
    Circulation; 2004 Jan; 109(2):201-6. PubMed ID: 14707020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of carvedilol on parameters of myocardial perfusion in patients with left ventricular remodeling after myocardial infarction].
    Kardiologiia; 2009; 49(2):66. PubMed ID: 19254220
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiac remodeling in coronary artery disease.
    Sharpe N
    Am J Cardiol; 2004 May; 93(9A):17B-20B. PubMed ID: 15144932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study.
    Ferrari R;
    Arch Intern Med; 2006 Mar; 166(6):659-66. PubMed ID: 16567606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
    Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
    Hoshikawa E; Matsumura Y; Kubo T; Okawa M; Yamasaki N; Kitaoka H; Furuno T; Takata J; Doi YL
    Am J Cardiol; 2011 Apr; 107(7):1065-70. PubMed ID: 21296328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
    Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
    J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carvedilol prevents remodeling in patients with left ventricular dysfunction after acute myocardial infarction.
    Senior R; Basu S; Kinsey C; Schaeffer S; Lahiri A
    Am Heart J; 1999 Apr; 137(4 Pt 1):646-52. PubMed ID: 10097224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of carvedilol as a concomitant therapy to angiotensin-converting enzyme inhibitor in patients with ischemic left ventricular systolic dysfunction.
    Gandhi PS; Goyal RK; Jain AR; Mallya BS; Gupta VM; Shah DS; Trivedi BR; Shastri NA; Mehta CB; Jain KA; Bhavasar NS; Shah UJ
    Can J Physiol Pharmacol; 2007 Feb; 85(2):193-9. PubMed ID: 17487260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta blockers or angiotensin-converting-enzyme inhibitor/angiotensin receptor blocker: what should be first?
    Remme WJ
    Cardiol Clin; 2007 Nov; 25(4):581-94; vii. PubMed ID: 18063162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correction of baroreflex sensitivity impairment and efficacy of prevention of sudden arrhythmic death in patients with postinfarction left ventricular dysfunction].
    Kanopskiĭ SG; Staritskiĭ AG; Bozhko AA
    Kardiologiia; 2004; 44(10):13-8. PubMed ID: 15477784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carvedilol may alleviate late cardiac remodelling following surgical ventricular restoration.
    Yoshikawa E; Marui A; Tsukashita M; Nishina T; Wang J; Muranaka H; Ikeda T; Komeda M
    Eur J Cardiothorac Surg; 2010 Feb; 37(2):362-7. PubMed ID: 19692266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular remodeling and ventricular arrhythmias after myocardial infarction.
    St John Sutton M; Lee D; Rouleau JL; Goldman S; Plappert T; Braunwald E; Pfeffer MA
    Circulation; 2003 May; 107(20):2577-82. PubMed ID: 12732606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
    Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
    Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of perindopril on cardiac remodelling and prognostic value of pre-discharge quantitative echocardiographic parameters in elderly patients after acute myocardial infarction: the PREAMI echo sub-study.
    Nicolosi GL; Golcea S; Ceconi C; Parrinello G; Decarli A; Chiariello M; Remme WJ; Tavazzi L; Ferrari R;
    Eur Heart J; 2009 Jul; 30(13):1656-65. PubMed ID: 19406871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.